UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031681
Receipt number R000036187
Scientific Title Minimal Effective dose of Lactic fermented egg white on the visceral fat obesity in Japanese men:doule-blind,parallel-armed study
Date of disclosure of the study information 2018/03/12
Last modified on 2018/03/12 15:10:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Minimal Effective dose of Lactic fermented egg white on the visceral fat obesity in Japanese men:doule-blind,parallel-armed study

Acronym

Minimal Effective dose of Lactic fermented egg white on the visceral fat obesity in Japanese men

Scientific Title

Minimal Effective dose of Lactic fermented egg white on the visceral fat obesity in Japanese men:doule-blind,parallel-armed study

Scientific Title:Acronym

Minimal Effective dose of Lactic fermented egg white on the visceral fat obesity in Japanese men

Region

Japan


Condition

Condition

veseral fat obesity

Classification by specialty

Medicine in general

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We comfirmed that minimale effective dose of fermemted egg white(LE) on the visceral fat by the coule-blind,parallel-arm design examination.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

visceral fat

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

The subjects intake the beverages with lactic fermented egg white 8g each day about 8 weeks. We checked thier visceral fats in baseline and week 8 of intake and abdominal girth in baesline and week 8.

Interventions/Control_2

The subjects intake the beverages with milk protein 8g each day about 8 weeks. We checked thier visceral fats in baseline and week 8 of intake and abdominal girth in baesline and week 8.

Interventions/Control_3

The subjects intake the beverages with lactic fermented egg white 6g each day about 8 weeks. We checked thier visceral fats in baseline and week 8 of intake and abdominal girth in baesline and week 8.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

The male subjects are older than 40 years old and youger than 70 years old.
The female subjects are postmenopausal and youger than 70 years old.
Bodymass index(>=24)
The person who dose not take medicine

Key exclusion criteria

The person who was told not to be suitable by the judgment of the doctor

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Tanaka

Organization

Kagawa Nutrition University

Division name

Nutrition Clinic

Zip code


Address

3-24-3 Komagome,Toshimaku,Tokyo.

TEL

03-3918-6181

Email

clinic@eiyo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Keiko Kamachi

Organization

Kagawa Nutrition University

Division name

Nutrition Clinic

Zip code


Address

3-24-3 Komagome,Toshimaku,Tokyo.

TEL

03-3918-6181

Homepage URL


Email

clinic@eiyo.ac.jp


Sponsor or person

Institute

Kagawa Nutrition University

Institute

Department

Personal name



Funding Source

Organization

Kewpie Corpration

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

女子栄養大学 栄養クリニック


Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 03 Month 14 Day

Date of IRB


Anticipated trial start date

2012 Year 03 Month 14 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 03 Month 12 Day

Last modified on

2018 Year 03 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036187


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name